Back to results
US 2013/0253199 A1Published application
Polymorphic Forms of Naltrexone
AssigneeAlkermes, Inc.
InventorsHarry G. Brittain, David A. Dickason, Joyce M. Hotz, Shawn L. Lyons, J. Michael Ramstack, Steven G. Wright
Life of this patent
Estimating the term…
Abstract
This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
Claims11
(canceled)
A crystalline naltrexone dichloromethane solvate.
A pharmaceutical composition comprising a crystalline naltrexone dichloromethane solvate.
Dependencies are inferred from the claim text.